Literature DB >> 15504344

Ceramide kinase targeting and activity determined by its N-terminal pleckstrin homology domain.

Adeline Carré1, Christine Graf, Samantha Stora, Diana Mechtcheriakova, Robert Csonga, Nicole Urtz, Andreas Billich, Thomas Baumruker, Frédéric Bornancin.   

Abstract

The N-terminus of ceramide kinase (CERK) is thought to be myristoylated and to contain a pleckstrin homology (PH) domain. We found that deletion of this region (DeltaPH-CERK) ablates activity. This is not due to prevention of N-terminal myristoylation since a G2A CERK mutant, which cannot be myristoylated, was active. CERK was able to bind liposomes, as well as the isolated unmyristoylated PH domain; DeltaPH-CERK was not. Upon analysis of EGFP-tagged proteins, CERK was found associated with the Golgi complex. Osmotic cell swelling induced translocation of CERK to the plasma membrane and formation of large vesicles displaying bound CERK. None of these features occurred with DeltaPH-CERK, which remained disseminated throughout the cytoplasm. These findings show that the PH domain of CERK is essential for localization, translocation, and activity of this lipid kinase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504344     DOI: 10.1016/j.bbrc.2004.09.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2013-11-05

2.  A critical beta6-beta7 loop in the pleckstrin homology domain of ceramide kinase.

Authors:  Philipp Rovina; Markus Jaritz; Siegfried Höfinger; Christine Graf; Piroska Dévay; Andreas Billich; Thomas Baumruker; Frédéric Bornancin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

3.  The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.

Authors:  Oleksandr Pastukhov; Stephanie Schwalm; Uwe Zangemeister-Wittke; Doriano Fabbro; Frederic Bornancin; Lukasz Japtok; Burkhard Kleuser; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 4.  Localization and function of cytosolic phospholipase A2alpha at the Golgi.

Authors:  Christina C Leslie; Todd A Gangelhoff; Michael H Gelb
Journal:  Biochimie       Date:  2010-03-10       Impact factor: 4.079

5.  Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells.

Authors:  Brian M Barth; Sally J Gustafson; Jody L Hankins; James M Kaiser; Jeremy K Haakenson; Mark Kester; Thomas B Kuhn
Journal:  Cell Signal       Date:  2011-12-30       Impact factor: 4.315

Review 6.  The role of ceramide-1-phosphate in biological functions.

Authors:  L Alexis Hoeferlin; Dayanjan S Wijesinghe; Charles E Chalfant
Journal:  Handb Exp Pharmacol       Date:  2013

7.  A conserved cysteine motif is critical for rice ceramide kinase activity and function.

Authors:  Fang-Cheng Bi; Quan-Fang Zhang; Zhe Liu; Ce Fang; Jian Li; Jian-Bin Su; Jean T Greenberg; Hong-Bin Wang; Nan Yao
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

8.  A Nonradioactive Fluorimetric SPE-Based Ceramide Kinase Assay Using NBD-C(6)-Ceramide.

Authors:  Helena Van Overloop; Gerd Van der Hoeven; Paul P Van Veldhoven
Journal:  J Lipids       Date:  2012-07-26

9.  CERKL knockdown causes retinal degeneration in zebrafish.

Authors:  Marina Riera; Demian Burguera; Jordi Garcia-Fernàndez; Roser Gonzàlez-Duarte
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

10.  Ceramide Kinase Is Upregulated in Metastatic Breast Cancer Cells and Contributes to Migration and Invasion by Activation of PI 3-Kinase and Akt.

Authors:  Stephanie Schwalm; Martin Erhardt; Isolde Römer; Josef Pfeilschifter; Uwe Zangemeister-Wittke; Andrea Huwiler
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.